F. Barry Bays - 05 Oct 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Director
Signature
/s/ Lisa Taylor as Attorney-in-fact for F. Barry Bays
Issuer symbol
TMCI
Transactions as of
05 Oct 2022
Net transactions value
-$680,323
Form type
4
Filing time
07 Oct 2022, 18:01:07 UTC
Previous filing
29 Sep 2022
Next filing
20 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Sale $367,272 -16,274 -0.99% $22.57 1,629,127 05 Oct 2022 Direct F1, F2
transaction TMCI Common Stock Sale $313,052 -13,500 -0.83% $23.19 1,615,627 06 Oct 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.23 to $23.16 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.57 to $23.48 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.